Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients

This publication has 38 references indexed in Scilit:

• Tissue Plasminogen Activator, Plasminogen Activator Inhibitor-1, and Tissue Plasminogen Activator/Plasminogen Activator Inhibitor-1 Complex as Risk Factors for the Development of a First Stroke
  Stroke, 2000
• Does hypertension confer a hypercoagulable state?
  Journal Of Hypertension, 1998
• Dietary docosahexaenoic acid reduces the thromboxane/prostacyclin synthetic ratio in humans
  The Journal of Nutritional Biochemistry, 1998
• Interactions Between Dietary Fat, Fish, and Fish Oils and Their Effects on Platelet Function in Men at Risk of Cardiovascular Disease
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Impaired endothelial function with essential hypertension assessed by ultrasonography
  American Heart Journal, 1996
• Improvement of Coronary Vasomotion With Eicosapentaenoic Acid Does Not Inhibit Acetylcholine-Induced Coronary Vasospasm in Patients With Variant Angina.
  Japanese Circulation Journal, 1995
• Effects of a Small Quantity of ω-3 Fatty Acids on Cardiovascular Risk Factors in NIDDM: A randomized, prospective, double-blind, controlled study
  Diabetes Care, 1994
• Associations of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable profile. The Atherosclerosis Risk in Communities (ARIC) Study.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Differential effect of aspirin on platelet aggregation in IDDM
  Diabetes, 1992
• Analysis of serial measurements in medical research.
  BMJ, 1990